Qiang Wang

5PUBLICATIONS
3CO-AUTHORS
Molecular targetsRespiratory diseasesPredictive and prognostic markersRheumatology and arthritisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 26, 2023
ACSL4 inhibition prevents macrophage ferroptosis and alleviates fibrosis in bleomycin-induced systemic sclerosis model.

Dianyu Cao, Jina Zheng, Zheng Li

|Sep 28, 2023
Dangui Huoxue Preparation (DHP) Ameliorates Skin Fibrosis, Inflammation, and Vasculopathy in the Bleomycin-Induced Murine Model of Systemic Sclerosis.

Yuemei Yan, Dianyu Cao, Jian Liang

|Jun 21, 2022
Myeloid cell-specific deletion of Capns1 prevents macrophage polarization toward the M1 phenotype and reduces interstitial lung disease in the bleomycin model of systemic sclerosis.

Li Zhang, Dong Zheng, Yuemei Yan

|May 13, 2020
Increased serum calpain activity is associated with HMGB1 levels in systemic sclerosis.

Ji-Na Zheng, Yang Li, Yue-Mei Yan

|Jul 05, 2019
Comparative efficacy and safety of immunosuppressive therapies for systemic sclerosis related interstitial lung disease: A Bayesian network analysis.

Ji-Na Zheng, Qiao-Rong Yang, Gui-Qi Zhu

Pageof 1

Frequent Collaborators

1 joint publications

Ji-Na Zheng

1 joint publications

Gui-Qi Zhu

1 joint publications

Xin Cao